RapidTradeView
Back to search

RapidTradeView

Picks for 2026-09-09

Algorithmically ranked US stock and ETF setups published on this trading day. Not financial advice.

  1. FRTFederal Realty Investment Trust

    Federal Realty Investment Trust (FRT) is seeing increased investor interest following its strong Q2 2026 results, which included a 6.8% year-over-year increase in core funds from operations and a 3% boost to its quarterly dividend, extending its 59-year streak of dividend hikes. This positive news, coupled with plans to redevelop one of its Phoenix retail properties into a mixed-use residential and retail space, is likely driving the recent volatility squeeze and volume surge as the price remains quiet near support.

    Grading: settles five trading days after publication.

  2. NESRNational Energy Services Reunited Corp.

    NESR is seeing positive momentum driven by recent strong earnings and new contract wins. The company reported robust second-quarter 2026 financial results on August 10th, with revenue up 59.1% year-over-year, and secured $300 million in multiple services and technology contracts in Kuwait on August 5th. This positive news has led to analysts raising their price targets and a "Strong Buy" consensus rating for the stock.

    Grading: settles five trading days after publication.

  3. STOKStoke Therapeutics, Inc.

    STOK is seeing downward pressure today after Simply Wall St published an article on September 8, 2026, suggesting the stock may be fully priced based on its pipeline hopes, despite a significant 4.8x return over the past three years. The article highlights that current market multiples appear overvalued and that the investment case heavily relies on the drug pipeline converting into meaningful revenue, leaving less room for disappointment if development takes longer or requires more capital. This comes after Stoke Therapeutics and Biogen presented long-term clinical data for their Dravet syndrome treatment, zorevunersen, at the 16th European Epilepsy Congress on September 3, 2026, which supported its disease-modifying potential.

    Grading: settles five trading days after publication.

All published briefings · Full scoreboard · Today's live board